A California biotech launched on Tuesday morning to try to bring a niche pain drug, approved in Italy for more than a decade, to the US.
Investors are pumping $125 million into the company, called …
Empower Pharmacy, a large GLP-1 compounding pharmacy that’s faced allegations of poor quality drugs and a legal challenge from Eli Lilly, has stopped operations at
The European Commission has unveiled a long-awaited proposal to make Europe a “biotech powerhouse” by speeding up clinical trials, extending intellectual property protection and boosting
The Biosecure Act is slated to become law after the Senate on Wednesday passed a defense bill that includes the measure. It’s a development that
HHS Secretary Robert F. Kennedy Jr. added two conditions to a federal newborn screening list, reviving efforts that had been stalled under the Trump administration
The CDC adopted new hepatitis B vaccine recommendations, eliminating the universal birth dose guidance that had been on the books for decades. The agency now
A California biotech launched on Tuesday morning to try to bring a niche pain drug, approved in Italy for more than a decade, to the US.
Investors are pumping $125 million into the company, called …